| Cover | Apr. 01, 2024 |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Apr. 01, 2024 |
| Entity File Number | 001-41282 |
| Entity Registrant Name | SUNSHINE BIOPHARMA, INC. |
| Entity Central Index Key | 0001402328 |
| Entity Tax Identification Number | 20-5566275 |
| Entity Incorporation, State or Country Code | CO |
| Entity Address, Address Line One | 1177 Avenue of the Americas, |
| Entity Address, Address Line Two | 5th Floor |
| Entity Address, City or Town | New York |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 10036 |
| City Area Code | (332) |
| Local Phone Number | 216-1147 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | false |
| Common Stock [Member] | |
| Title of 12(b) Security | Common Stock, par value $0.001 |
| Trading Symbol | SBFM |
| Security Exchange Name | NASDAQ |
| Common Stock Purchase Warrants [Member] | |
| Title of 12(b) Security | Common Stock Purchase Warrants |
| Trading Symbol | SBFMW |
| Security Exchange Name | NASDAQ |
